These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32127901)
1. The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma. Dane C; Bakir S Afr Health Sci; 2019 Dec; 19(4):3235-3241. PubMed ID: 32127901 [TBL] [Abstract][Full Text] [Related]
2. Parametrial spread is a prognostic factor in endometrial carcinoma. Sato R; Jobo T; Kuramoto H Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232 [TBL] [Abstract][Full Text] [Related]
3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832 [TBL] [Abstract][Full Text] [Related]
5. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of gross myometrial invasion with endometrial cancer. Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246 [TBL] [Abstract][Full Text] [Related]
7. The significance of the degree of myometrial invasion in patients with stage IB endometrial cancer. Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S Eur J Gynaecol Oncol; 2004; 25(3):336-8. PubMed ID: 15171313 [TBL] [Abstract][Full Text] [Related]
8. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer. Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
10. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
11. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection]. Ivanov I Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272 [TBL] [Abstract][Full Text] [Related]
12. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma]. Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
14. Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry. Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ Int J Gynecol Cancer; 2004; 14(4):665-72. PubMed ID: 15304163 [TBL] [Abstract][Full Text] [Related]
15. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Longacre TA; Hendrickson MR Am J Surg Pathol; 1999 Jan; 23(1):69-78. PubMed ID: 9888705 [TBL] [Abstract][Full Text] [Related]
16. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Ytre-Hauge S; Husby JA; Magnussen IJ; Werner HM; Salvesen ØO; Bjørge L; Trovik J; Stefansson IM; Salvesen HB; Haldorsen IS Int J Gynecol Cancer; 2015 Mar; 25(3):459-66. PubMed ID: 25628109 [TBL] [Abstract][Full Text] [Related]
17. The grading of lymphovascular space invasion in endometrial carcinoma. Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436 [TBL] [Abstract][Full Text] [Related]
18. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer. Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. Zhang C; Wang C; Feng W Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266 [TBL] [Abstract][Full Text] [Related]
20. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]